Fund Overview of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
-
₹6,104.0 CrAUM
-
₹39.76NAV
-
1.87%Expense Ratio
-
EquityFund Category
Returns of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 2.88% | NA | 6.12% |
| 6 Months | 16.94% | NA | 12.92% |
| 1 Year | 3.70% | 3.70% | 6.04% |
| 2 Years | 66.20% | 28.92% | 24.93% |
| 3 Years | 116.82% | 29.43% | 25.71% |
| 5 Years | 155.59% | 20.65% | 19.91% |
| 7 Years | 271.92% | 20.64% | NA |
Asset Allocation
equities
95.89%other assets or cash equivalents
4.11%ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 13 Jul 2018, the fund aims Long term wealth creation. An equity Scheme that predominantly invests in pharma, healthcare, hospitals, diagnostics, wellness and allied companies. It manages assets worth ₹6,104.0 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹33.80 and ₹41.47. The expense ratio stands at 1.87%. Fund Manager Manager Education Fund Manager Manager EducationAbout ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
The portfolio allocation consists of 95.89% in equities, 4.11% in other assets or cash equivalents. Managed by Dharmesh Kakkad, it has delivered a return of 3.70% in the last year, a total return since inception of 21.56%.
Key Metrics of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
-
Standard Deviation15.51%
-
Sharpe Ratio1.27%
-
Alpha3.55%
-
Beta0.94%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
Tata India Pharma & Healthcare Fund Regular-growth  |
₹1,339 | -1.01% | -0.31% | -2.45% | 21.59% | 16.66% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from ICICI Prudential Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
|
₹6,104 | -0.86% | -0.44% | 13.38% | 2.75% | 27.60% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
|
₹6,104 | -0.93% | -0.65% | 12.92% | 1.91% | 26.54% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
|
₹6,104 | -0.86% | -0.44% | 13.38% | 2.75% | 27.60% |
|
ICICI Prudential Nifty Healthcare Etf - Growth
|
₹146 | 0.09% | -0.81% | 9.25% | -1.30% | 20.85% |
|
ICICI Prudential Nifty Pharma Index Fund - Growth
|
₹95 | -0.79% | -2.09% | 6.44% | -7.13% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Growth
|
₹95 | -0.74% | -1.94% | 6.77% | -6.58% | - |
|
ICICI Prudential Nifty Pharma Index Fund - Idcw
|
₹95 | -0.79% | -2.09% | 6.44% | -7.13% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Idcw
|
₹95 | -0.74% | -1.94% | 6.77% | -6.58% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Tax Information
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹1,339 | ₹30.46 | 21.59% | 16.66% | - |
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct - Growth |
₹166 | ₹20.67 | 19.25% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.69% | ₹713.48 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 8.85% | ₹540.22 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.13% | ₹496.29 Cr |
| Cipla Ltd | Healthcare | 7.54% | ₹460.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.71% | ₹348.35 Cr |
| Lupin Ltd | Healthcare | 5.11% | ₹312.02 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.88% | ₹236.58 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.83% | ₹234.03 Cr |
| Biocon Ltd | Healthcare | 3.64% | ₹222.32 Cr |
| Repo | Unspecified | 3.60% | ₹220.04 Cr |
| Gland Pharma Ltd | Healthcare | 3.20% | ₹195.59 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.97% | ₹181.51 Cr |
| Syngene International Ltd | Healthcare | 2.50% | ₹152.34 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.72% | ₹105.07 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.62% | ₹99.17 Cr |
| Pfizer Ltd | Healthcare | 1.54% | ₹94.00 Cr |
| Sagility India Ltd. | Industrials | 1.53% | ₹93.24 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.44% | ₹88.17 Cr |
| Medplus Health Services Ltd | Healthcare | 1.43% | ₹87.20 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.40% | ₹85.55 Cr |
| Windlas Biotech Ltd | Healthcare | 1.39% | ₹84.83 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.32% | ₹80.84 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.32% | ₹80.79 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.31% | ₹79.91 Cr |
| Fine Organic Industries Ltd | Materials | 1.31% | ₹79.67 Cr |
| Aarti Drugs Ltd | Healthcare | 1.28% | ₹78.18 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.23% | ₹74.82 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.16% | ₹70.77 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.07% | ₹65.18 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.04% | ₹63.43 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.95% | ₹58.10 Cr |
| Fdc Ltd | Healthcare | 0.94% | ₹57.41 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹51.87 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.83% | ₹50.54 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.75% | ₹45.99 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.72% | ₹44.15 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.67% | ₹40.87 Cr |
| Net Current Assets | Unspecified | 0.37% | ₹22.68 Cr |
| Cash Margin | Unspecified | 0.14% | ₹8.41 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth |
₹30.46 | 21.59% | 16.66% | 32.01 |
growth is based on 5Y returns of the funds
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
What is the current AUM of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
As of Thu Jul 31, 2025, ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth manages assets worth ₹6,104.0 crore
How has ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth performed recently?
- 3 Months: 2.88%
- 6 Months: 16.94%
What is the long-term performance of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
- 3 Years CAGR: 29.43%
- 5 Years CAGR: 20.65%
- Since Inception: 21.56%
What is the portfolio composition of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
Equity: 95.89%, Others: 4.11%.
Who manages ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth is managed by Dharmesh Kakkad from ICICI Prudential Mutual Fund.
What is the market-cap allocation of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
Large Cap: 50.24%, Mid Cap: 16.50%, Small Cap: 33.26%.
Which are the top companies ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.69% of the fund's portfolio
- Dr. Reddy's Laboratories Ltd – 8.85% of the fund's portfolio
- Divi's Laboratories Ltd – 8.13% of the fund's portfolio
- Cipla Ltd – 7.54% of the fund's portfolio
- Aurobindo Pharma Ltd – 5.71% of the fund's portfolio
Which are the major sectors ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth focuses on?
- Healthcare – 89.71% of the fund's portfolio
- Unspecified – 4.11% of the fund's portfolio
- Industrials – 2.85% of the fund's portfolio
- Materials – 2.26% of the fund's portfolio
- Financial – 1.07% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
